We are a world-leading consumer health companywith a clear purpose to deliver better everyday health with humanity.
Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally. Haleon has a strong portfolio of brands and is well positioned to play a vital role for people all around the world, in a sector that is growing and more relevant than ever.
The definition of consumer healthcare varies across competitors and industry data sources. We define it as consisting of Oral Health, VMS and Over-the-Counter (OTC). Within OTC, Haleon's portfolio comprises of Pain, Respiratory, Digestive and Other.
2022
Served areaWorldwide
Headcount24,622
HeadquartersBuilding 5, First Floor, The Heights, KT13 0NY Weybridge – United Kingdom
9,230,000,000
IPOJuly 18, 2022
Stock exchange(s)London Stock Exchange